Colonisation endpoints in Streptococcus pneumoniae vaccine trials
- 1 December 2013
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 32 (1), 153-158
- https://doi.org/10.1016/j.vaccine.2013.08.061
Abstract
No abstract availableFunding Information
- Bill and Melinda Gates Foundation
- Pfizer
This publication has 20 references indexed in Scilit:
- How Is Vaccine Effectiveness Scaled by the Transmission Dynamics of Interacting Pathogen Strains with Cross-Protective Immunity?PLOS ONE, 2012
- Pneumococcal Conjugate Vaccine Given Shortly After Birth Stimulates Effective Antibody Concentrations and Primes Immunological Memory for Sustained Infant ProtectionClinical Infectious Diseases, 2011
- Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancyVaccine, 2010
- Estimation of vaccine efficacy against acquisition of pneumococcal carriageVaccine, 2009
- Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control studyThe Lancet, 2006
- Serum Serotype‐Specific Pneumococcal Anticapsular Immunoglobulin G Concentrations after Immunization with a 9‐Valent Conjugate Pneumococcal Vaccine Correlate with Nasopharyngeal Acquisition of PneumococcusThe Journal of Infectious Diseases, 2005
- Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysisBMJ, 2003
- Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate VaccineThe Journal of Infectious Diseases, 1999
- The Impact Of Conjugate Vaccine On Carriage Of Haemophilus Influenzae Type BThe Journal of Infectious Diseases, 1995
- Pneumococcal Disease after Pneumococcal VaccinationThe New England Journal of Medicine, 1980